FDA recommendation News
Most Popular FDA recommendation Story
FDA committee backs Lilly's prasugrel
After months of delays, Eli Lilly and Daiichi Sankyo finally have word on the status of their anti-clotting drug prasugrel. An FDA advisory committee released a hefty briefing on prasugrel, ahead of Read more...
Latest Headlines
- October 6, 2009
- October 6, 2009
- April 1, 2009
- January 30, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
